184 related articles for article (PubMed ID: 25222591)
1. Disparity in post-treatment maternal circulating magnesium sulfate levels between twin and singleton gestation: Is this the missing link between plurality and adverse outcome?
Marom-Haham L; Mazaki-Tovi S; Zilberman I; Kalter A; Haas J; Sivan E; Schiff E; Yinon Y
J Perinat Med; 2015 Sep; 43(5):585-90. PubMed ID: 25222591
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting maternal serum magnesium levels during long-term magnesium sulfate tocolysis in singleton and twin pregnancy.
Nakazawa H; Uchida A; Minamitani T; Makishi A; Takamatsu Y; Kiyoshi K; Samoto T; Funakoshi T
J Obstet Gynaecol Res; 2015 Aug; 41(8):1178-84. PubMed ID: 25857633
[TBL] [Abstract][Full Text] [Related]
3. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
Bachnas MA; Mose JC; Effendi JS; Andonotopo W
J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
[TBL] [Abstract][Full Text] [Related]
4. Maternal obesity and neuroprotective magnesium sulfate.
McPherson J; Smiley S; Stamilio D
Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
[TBL] [Abstract][Full Text] [Related]
5. Increasing amniotic fluid magnesium concentrations with stable maternal serum levels: a prospective clinical trial.
Gortzak-Uzan L; Mezad D; Smolin A; Friger M; Huleihel M; Hallak M
J Reprod Med; 2005 Nov; 50(11):817-20. PubMed ID: 16419627
[TBL] [Abstract][Full Text] [Related]
6. [Neuroprotection for preterm infants with antenatal magnesium sulphate].
Marret S; Ancel PY
J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1418-1433. PubMed ID: 28166926
[TBL] [Abstract][Full Text] [Related]
7. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
[TBL] [Abstract][Full Text] [Related]
8. Association of duration of neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes.
McPherson JA; Rouse DJ; Grobman WA; Palatnik A; Stamilio DM
Obstet Gynecol; 2014 Oct; 124(4):749-755. PubMed ID: 25198275
[TBL] [Abstract][Full Text] [Related]
9. Serum magnesium levels during magnesium sulfate tocolysis in high-order multiple gestations.
Elliott JP; Radin TG
J Reprod Med; 1995 Jun; 40(6):450-2. PubMed ID: 7650659
[TBL] [Abstract][Full Text] [Related]
10. Intravenous magnesium sulfate for premature labor: comparison between twin and singleton gestations.
Hales KA; Matthews JP; Rayburn WF; Atkinson BD
Am J Perinatol; 1995 Jan; 12(1):7-10. PubMed ID: 7710584
[TBL] [Abstract][Full Text] [Related]
11. Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial.
Wolf HT; Brok J; Henriksen TB; Greisen G; Salvig JD; Pryds O; Hedegaard M; Weber T; Hegaard HK; Pinborg A; Huusom LD;
BJOG; 2020 Sep; 127(10):1217-1225. PubMed ID: 32237024
[TBL] [Abstract][Full Text] [Related]
12. Outcomes after physical examination-indicated cerclage in twin gestations.
Miller ES; Rajan PV; Grobman WA
Am J Obstet Gynecol; 2014 Jul; 211(1):46.e1-5. PubMed ID: 24657791
[TBL] [Abstract][Full Text] [Related]
13. Impact of dosing schedule on uptake of neuroprotective magnesium sulfate.
Cuff RD; Sullivan SA; Chang EY
J Matern Fetal Neonatal Med; 2020 Mar; 33(6):982-986. PubMed ID: 30122071
[No Abstract] [Full Text] [Related]
14. Association between Cerebral Palsy or Death and Umbilical Cord Blood Magnesium Concentration.
Palatnik A; Rouse DJ; Stamilio DM; McPherson JA; Grobman WA
Am J Perinatol; 2015 Nov; 32(13):1263-7. PubMed ID: 26058371
[TBL] [Abstract][Full Text] [Related]
15. Maternal and fetal serum concentrations of magnesium after administration of a 6-g bolus dose of magnesium sulfate (MgSO
Jonsdotter A; Rocha-Ferreira E; Hagberg H; Carlsson Y
Acta Obstet Gynecol Scand; 2022 Aug; 101(8):856-861. PubMed ID: 35501953
[TBL] [Abstract][Full Text] [Related]
16. Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial.
Bain ES; Middleton PF; Yelland LN; Ashwood PJ; Crowther CA
BJOG; 2014 Apr; 121(5):595-603. PubMed ID: 24387624
[TBL] [Abstract][Full Text] [Related]
17. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study.
Riaz M; Porat R; Brodsky NL; Hurt H
J Perinatol; 1998; 18(6 Pt 1):449-54. PubMed ID: 9848759
[TBL] [Abstract][Full Text] [Related]
18. Racial/ethnic disparities in magnesium sulfate neuroprotection: a subgroup analysis of a multicenter randomized controlled trial.
Vilchez G; Dai J; Kumar K; Mundy D; Kontopoulos E; Sokol RJ
J Matern Fetal Neonatal Med; 2018 Sep; 31(17):2304-2311. PubMed ID: 28612671
[TBL] [Abstract][Full Text] [Related]
19. The neuroprotective effect of magnesium sulfate in preterm fetal mice.
Cho GJ; Hong HR; Hong SC; Oh MJ; Kim HJ
J Perinat Med; 2015 Sep; 43(5):537-43. PubMed ID: 25503462
[TBL] [Abstract][Full Text] [Related]
20. Maternal magnesium level effect on preterm labor treatment.
Uludağ EÜ; Gözükara IÖ; Kucur SK; Uluğ P; Özdeğirmenci Ö; Erkaya S
J Matern Fetal Neonatal Med; 2014 Sep; 27(14):1449-53. PubMed ID: 24156667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
